These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 1981317)
1. Withdrawal phenomena after atenolol and bopindolol: hormonal changes in normal volunteers. Walden RJ; Tomlinson B; Graham B; Smith C; Betteridge DJ; Prichard BN Br J Clin Pharmacol; 1990 Oct; 30(4):547-56. PubMed ID: 1981317 [TBL] [Abstract][Full Text] [Related]
2. Withdrawal phenomena after atenolol and bopindolol: haemodynamic responses in healthy volunteers. Walden RJ; Tomlinson B; Graham B; Liu JB; Prichard BN Br J Clin Pharmacol; 1990 Oct; 30(4):557-65. PubMed ID: 1981318 [TBL] [Abstract][Full Text] [Related]
3. Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension. Schiess W; Welzel D; Gugler R Eur J Clin Pharmacol; 1984; 27(5):529-34. PubMed ID: 6151506 [TBL] [Abstract][Full Text] [Related]
4. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension. Colnago R; Meregalli M; Turri D; Nazzari M; Fiorella G; Guffanti EE; Mazzola C Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520 [TBL] [Abstract][Full Text] [Related]
5. Withdrawal of the long-acting beta blocker bopindolol is not associated with beta-adrenoceptor supersensitivity. Bolli P; Amann FW; Müller FB; Meyer B; Burckhardt D; Bühler FR J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S64-9. PubMed ID: 2439824 [TBL] [Abstract][Full Text] [Related]
6. Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease. Schiess W; Dorow P J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S30-3. PubMed ID: 2439815 [TBL] [Abstract][Full Text] [Related]
7. The antihypertensive effect of atenolol and bopindolol in the elderly. Viskoper RJ; Laszt A; Oren S; Hochberg Y; Villa Y; Drexler I; Bregman L; Mishal J Neth J Med; 1989 Oct; 35(3-4):185-91. PubMed ID: 2574832 [TBL] [Abstract][Full Text] [Related]
8. The effect of intrinsic sympathomimetic activity on beta-receptor responsiveness after beta-adrenoceptor blockade withdrawal. Walden RJ; Bhattacharjee P; Tomlinson B; Cashin J; Graham BR; Prichard BN Br J Clin Pharmacol; 1982; 13(Suppl 2):359S-364S. PubMed ID: 6125188 [TBL] [Abstract][Full Text] [Related]
9. Haemodynamic effects of atenolol and bopindolol at rest and during isometric exercise. A non-invasive study in healthy volunteers. Nieminen MS; Rapola J; Pellinen TJ; Toivonen L Ann Clin Res; 1988; 20(6):431-5. PubMed ID: 2905879 [TBL] [Abstract][Full Text] [Related]
10. Bopindolol: a slowly dissociating antagonist from the beta-adrenoceptors in guinea pig atria. Hosohata Y; Hattori K; Shen Y; Okuyama M; Kaneko H; Ohnuki T; Suzuki J; Nagatomo T Pharmacology; 1998 Oct; 57(4):180-7. PubMed ID: 9730775 [TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacological studies with the long-acting beta-adrenoceptor blocking drug bopindolol. Aellig WH J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S12-5. PubMed ID: 2439811 [TBL] [Abstract][Full Text] [Related]
12. Dose-finding study with bopindolol in arterial hypertension. Willimann P; Peter R; Siegenthaler H J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S25-9. PubMed ID: 2439814 [TBL] [Abstract][Full Text] [Related]
13. The offset of beta-adrenoceptor antagonism of the responses of the rat right ventricle to isoprenaline. Doggrell SA; Henderson CJ J Auton Pharmacol; 1998 Oct; 18(5):263-9. PubMed ID: 9831226 [TBL] [Abstract][Full Text] [Related]